
    
      This is a double-blind, randomised, placebo controlled, 2-way cross-over study to investigate
      the effects of a single dose of inhaled AZD7624 on white blood cells and inflammatory markers
      in induced sputum and blood after oral inhalation of LPS as well as the safety, tolerability
      and pharmacokinetics (PK) of AZD7624 following a single inhaled dose.
    
  